We are COPAN
February 28, 2014
COPAN Announces WASP® Distribution Agreement with Thermo Fisher Scientific Inc. in the United States
Click here to learn more >
Click here for complete
The Source of Respiratory Syncytial Virus Infection In Infants: A Household Cohort Study In Rural Kenya >
"Respiratory syncytial virus (RSV) vaccine development for direct protection of young infants faces substantial obstacles. Assessing the potential of indirect protection using different strategies, such as targeting older children or mothers, requires knowledge of the source of infection to the infants."
Want more Studies?
Click here to find more >